[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346638-105":59,"doc-detail-346638-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinct-expression-patterns-and-clinical-associations-of-the-irx-gene-family-across-hormone-sensitive-cancers","Distinct Expression Patterns and Clinical Associations of the IRX Gene Family Across Hormone-Sensitive Cancers","","Iroquois (IRX) homeobox genes regulate key developmental programs, yet their dysregulation in hormone-sensitive cancers remains incompletely defined. This study performs an exploratory analysis of IRX1–IRX6 across prostate, breast, ovarian, and endometrial cancers using large public transcriptomic datasets. IRX3 and IRX5 are elevated in estrogen-dependent tumors, while IRX2 and IRX4 show distinct cancer-specific upregulation. Clinically, IRX2 and IRX4 relate to prognosis and stemness-associated signatures, and IRX6 links with reduced abiraterone sensitivity, supporting marker potential for treatment response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinct-expression-patterns-and-clinical-associations-of-the-irx-gene-family-across-hormone-sensitive-cancers/346638/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinct-expression-patterns-and-clinical-associations-of-the-irx-gene-family-across-hormone-sensitive-cancers/346638.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which IRX genes were found to be elevated in estrogen-dependent tumors?","Question",{"text":112,"@type":113},"IRX3 and IRX5 were consistently elevated in estrogen-dependent cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What associations did IRX2 and IRX4 show with clinical outcomes and stemness?",{"text":117,"@type":113},"IRX2 expression was linked with favorable outcomes in breast, endometrial, and ovarian cancers and correlated with stemness-related signatures in prostate cancer; IRX4 expression was associated with stemness features in prostate and endometrial cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"How is IRX6 related to therapy response?",{"text":121,"@type":113},"IRX6 expression showed associations with reduced sensitivity to abiraterone, suggesting a potential connection to therapeutic resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346638,1790207091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nDistinct Expression Patterns and Clinical Associations of the IRX Gene Family Across Hormone-Sensitive Cancers  \nAmali Thennakoon 1,2,3, Achala Fernando 1,2,3 and Jyotsna Batra 1,2,3, *  \nAcademic Editor: James Hicks  \nReceived: 22 January 2026  \nRevised: 12 February 2026  \nAccepted: 19 February 2026  \nPublished: 24 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia; [t2.thennakoon@hdr.qut.edu.au](t2.thennakoon@hdr.qut.edu.au) (A.T.); [a.vitharanage@qut.edu.au](a.vitharanage@qut.edu.au) (A.F.)  \n2 Translational Research Institute, The Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD 4102, Australia  \n3 Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD 4226, Australia  \n* [Correspondence: jbatra@bond.edu.au](Correspondence: jbatra@bond.edu.au); Tel.: +61-(07)-3443-7336  \nSimple Summary  \nHormone-sensitive cancers such as prostate, breast, ovarian, and endometrial cancers are governed by hormone signals and often show differential responses to treatment. Understanding the genes involved in these cancers will help explain why some tumours behave more aggressively or become resistant to therapy. The Iroquois (IRX) gene family is known to play important roles during development, but their importance in hormonesensitive cancers is not well understood. In this study, we analyzed large public datasets to examine how IRX genes are expressed in different hormone-sensitive cancers and how their expression correlates to disease progression, patient outcomes, cancer stem-like features, and treatment response. We found that IRX genes show distinct patterns depending on cancer type. These findings provide a useful resource for researchers and highlight that IRX genes may act as potential markers of tumour behaviour that warrant further investigation.  \nAbstract  \nBackground/Objectives: The Iroquois (IRX) family of homeobox genes regulates critical developmental processes, and emerging evidence suggests that their dysregulation contributes to cancer progression, particularly in relation to cancer stemness. Although their expression appears to be influenced by hormonal regulation, their potential roles in hormone-sensitive cancers remain incompletely understood. Methods: In this study, we performed a comprehensive, exploratory analysis of all six Iroquois genes (IRX1–IRX6) across prostate, breast, ovarian, and endometrial cancers. Using large-scale publicly available transcriptomic datasets, we systematically examined IRX gene expression patterns and their associations with tumour progression, prognosis, hormone regulation, drug response, and cancer stemness. Results: IRX3 and IRX5 were consistently elevated in estrogen-dependent tumours and IRX2 and IRX4 were notably upregulated in prostate cancer. Despite evidence of estrogen receptor 1 (ESR1) and androgen receptor (AR) binding near several IRX promoters, estrogen treatment assays showed that ESR1 binding at promoters alone was insufficient to induce IRX transcription. Clinically, IRX2 expression was associated with favourable outcomes in breast, endometrial, and ovarian cancers and showed correlations with stemness-related signatures in prostate cancer. Similarly, IRX4 expression was associated with stemness features in prostate and endometrial cancers. In addition, IRX6 expression showed associations with reduced sensitivity to abiraterone, suggesting a potential link with therapeutic resistance in these tumours. Conclusions: Collectively, these findings highlight the context-dependent expression patterns and clinical associations of IRX genes across hormone-driven cancers. While largely correlative, this  \nstudy provides a f","cbCaieMXjC7UPwGf","https://ap.wps.com/l/cbCaieMXjC7UPwGf","pdf",3733205,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Which IRX genes were found to be elevated in estrogen-dependent tumors?\",\"answer\":\"IRX3 and IRX5 were consistently elevated in estrogen-dependent cancers.\"},{\"question\":\"What associations did IRX2 and IRX4 show with clinical outcomes and stemness?\",\"answer\":\"IRX2 expression was linked with favorable outcomes in breast, endometrial, and ovarian cancers and correlated with stemness-related signatures in prostate cancer; IRX4 expression was associated with stemness features in prostate and endometrial cancers.\"},{\"question\":\"How is IRX6 related to therapy response?\",\"answer\":\"IRX6 expression showed associations with reduced sensitivity to abiraterone, suggesting a potential connection to therapeutic resistance.\"}]","Distinct Expression Patterns and Clinical Associations of the IRX Gene Family Across Hormone-Sensitive Cancers | PDF",1790062208,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67fa9f1a7443ad7b980d3390cd1f619d.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/291005e90a921d8b542166f3b472e1a9.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a19d5f788520a8df957765c6d973f70a.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10eb75be726afdad1f3d1a393810eccd.webp",980,1385]